Skip to content

Clinical trials

Observational Coronary Artery Disease trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Observational Country / region: Germany Clear all

116 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20032
20042
20052
20061
20072
20088
20095
20105
20114
20127
20136
20146
20154
20169
201711
20186
20195
20206
20215
20224
20239
20241
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed62
Unknown status31
Recruiting15
Active, not recruiting4
Terminated3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Heinrich-Heine University, Duesseldorf5
University Hospital, Essen5
Abbott Medical Devices4
B. Braun Melsungen AG4
University Hospital Heidelberg4
Biotronik AG3
Charite University, Berlin, Germany3
Heidelberg University3
Johann Wolfgang Goethe University Hospital3
Johannes Gutenberg University Mainz3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease116
Cardiovascular Diseases13
Myocardial Ischemia10
Acute Coronary Syndrome9
Coronary Disease9
Heart Failure8
Heart Diseases7
Aortic Valve Stenosis6
Angina Pectoris5
Coronary Stenosis5

Trials

Showing 1 to 25 of 116. Each trial links to its page on Pharma Observatory.

16 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.